Visit schedule
| Test | Study visit | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 (Baseline) | 2 (4–6 weeks) | 3 (12th week) | 4 (14–16 weeks) | 5 (24 weeks) | 7 (28–32 weeks) | 8 (36th week) | End of study (48th week) | |
| Demographics | X | X | X | X | X | |||
| Medical history | X | X | X | X | X | |||
| Clinical assessment | X | X | X | X | X | |||
| SLEDAI assessment | X | X | X | X | X | |||
| Renal Function assessment | X | X | X | X | X | |||
| Immunological Study | X | X | X | X | X | |||
| Adverse event assessment | X | X | X | X | X | X | X | |
| Pharmacokinetic analysis— total 3 sampling occasions | ☼ | ☼ | ☼ | |||||